Griffin TW - Search Results

1

A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients.

Griffin TW, Bokhari F, Collins J, Stochl M, Bernier M, Gionet M, Siebecker D, Wertheimer M, Giroves ES, Greenfield L, et al. Griffin TW, et al. Cancer Immunol Immunother. 1989;29(1):43-50. doi: 10.1007/BF00199915. Cancer Immunol Immunother. 1989. PMID: 2706639 Free PMC article.

2

Pharmacokinetics of indium-111 labeled 10-3D2 antibreast-tumor antibody in patients.

Hnatowich DJ, Rusckowski M, Siebecker DA, Gionet M, Mardirossian G, Bushe HS, Roy S, Mattis JA, Shealy D, Griffin TW, et al. Hnatowich DJ, et al. Among authors: griffin tw. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):7-13. J Nucl Biol Med (1991). 1992. PMID: 1450229

3

Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.

Griffin TW, Brill AB, Stevens S, Collins JA, Bokhari F, Bushe H, Stochl MC, Gionet M, Rusckowski M, Stroupe SD, et al. Griffin TW, et al. J Clin Oncol. 1991 Apr;9(4):631-40. doi: 10.1200/JCO.1991.9.4.631. J Clin Oncol. 1991. PMID: 2066759

4

Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibody.

Hnatowich DJ, Chinol M, Siebecker DA, Gionet M, Griffin T, Doherty PW, Hunter R, Kase KR. Hnatowich DJ, et al. J Nucl Med. 1988 Aug;29(8):1428-35. J Nucl Med. 1988. PMID: 3404257 Free article.

5

Intraperitoneal immunoconjugates.

Griffin TW, Collins J, Bokhari F, Stochl M, Brill AB, Ito T, Emond G, Sands H. Griffin TW, et al. Cancer Res. 1990 Feb 1;50(3 Suppl):1031s-1038s. Cancer Res. 1990. PMID: 2404580 Clinical Trial.

6

Intratumoral and whole-body distributions of C110 anti-carcinoembryonic antigen radioimmunotoxin after intraperitoneal and intravenous injection: a quantitative autoradiographic study.

Ito T, Griffin TW, Collins JA, Brill AB. Ito T, et al. Among authors: griffin tw. Cancer Res. 1992 Apr 1;52(7):1961-7. Cancer Res. 1992. PMID: 1551124

7

Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.

Ito T, Qiu H, Collins JA, Brill AB, Johnson DK, Griffin TW. Ito T, et al. Among authors: griffin tw. Cancer Res. 1991 Jan 1;51(1):255-60. Cancer Res. 1991. PMID: 1988087

8

Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancer.

Hunter RE, Doherty P, Griffin TW, Gionet M, Hnatowich DJ, Bianco JA, Dillon MB. Hunter RE, et al. Among authors: griffin tw. Gynecol Oncol. 1987 Jul;27(3):325-39. doi: 10.1016/0090-8258(87)90254-x. Gynecol Oncol. 1987. PMID: 3497845

9

High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer.

Hunter RE, Griffin TW, Stevens S, Roman LD, Bokhari F, Reale FR, Tak WK, Fitzgerald TJ, Dillon MB, Rose PG. Hunter RE, et al. Among authors: griffin tw. Cancer. 1991 Nov 1;68(9):1890-4. doi: 10.1002/1097-0142(19911101)68:9<1890::aid-cncr2820680907>3.0.co;2-t. Cancer. 1991. PMID: 1655227 Clinical Trial.

10

Combined antitumor therapy with the chemotherapeutic drug doxorubicin and an anti-transferrin receptor immunotoxin: in vitro and in vivo studies.

Griffin TW, Stocl M, Collins J, Fernandes J, Maher VE. Griffin TW, et al. J Immunother (1991). 1992 Jan;11(1):12-8. doi: 10.1097/00002371-199201000-00002. J Immunother (1991). 1992. PMID: 1734944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters